EMC Insurance Group Inc. (EMCI) Is At $26.52 Formed Wedge; Meridian Bioscience (VIVO) SI Decreased By 3.11%

Meridian Bioscience, Inc. (NASDAQ:VIVO) Logo

Meridian Bioscience Inc (NASDAQ:VIVO) had a decrease of 3.11% in short interest. VIVO’s SI was 3.16M shares in June as released by FINRA. Its down 3.11% from 3.27M shares previously. With 287,300 avg volume, 11 days are for Meridian Bioscience Inc (NASDAQ:VIVO)’s short sellers to cover VIVO’s short positions. The SI to Meridian Bioscience Inc’s float is 7.61%. The stock increased 1.93% or $0.3 during the last trading session, reaching $15.85. About 153,774 shares traded. Meridian Bioscience, Inc. (NASDAQ:VIVO) has risen 6.09% since June 14, 2017 and is uptrending. It has underperformed by 6.48% the S&P500. Some Historical VIVO News: ; 01/04/2018 – Idaho DOL: WIOA Orient-Meridian; 19/04/2018 – WA State Auditor: Meridian School District No 505 Financial and Federal 4/19/2018 – 4/19/2018; 27/04/2018 – Meridian Debuts Career Development, Enhanced Privacy and Compliance Features; 14/03/2018 – Meridian Waste Solutions’ Attis Innovations Strikes Partnerships in Florida to Create Biomass Value from Rogued Citrus Trees; 22/03/2018 – U.S FDA PROVIDES STATEMENT ON FINDINGS FROM ONGOING INVESTIGATION INTO LEAD TESTING ISSUES; 15/03/2018 – Hackensack Meridian Health and Carrier Clinic Explore Partnership To Enhance Behavioral Health in Tri-State Area; 17/05/2018 – LINCOLN PROPERTY CO. BUYS MERIDIAN AT CARLYLE APARTMENTS; 26/04/2018 – Meridian Bioscience 2Q Adj EPS 21c; 21/03/2018 – Meridian Bioscience New Structure Consists of Two Business Units, Diagnostics and Life Science; 21/03/2018 – MERIDIAN BIOSCIENCE – FOR TIME BEING, JACK KENNY WILL ACT AS EXECUTIVE VICE PRESIDENT OF DIAGNOSTICS BUSINESS UNIT, IN ADDITION TO HIS ROLE AS CEO

EMC Insurance Group Inc. (EMCI) formed wedge down with $25.46 target or 4.00% below today’s $26.52 share price. EMC Insurance Group Inc. (EMCI) has $571.28 million valuation. The stock decreased 0.67% or $0.18 during the last trading session, reaching $26.52. About 20,826 shares traded or 21.57% up from the average. EMC Insurance Group Inc. (NASDAQ:EMCI) has declined 5.33% since June 14, 2017 and is downtrending. It has underperformed by 17.90% the S&P500. Some Historical EMCI News: ; 29/05/2018 – Apstra Deployed with Dell EMC and OPX by Awnix in Open laaS Network Infrastructure in Tier 1 Service Provider Cloud; 16/05/2018 – Sources: Dell EMC Establishes New Simplified Storage Product Lineup; 23/05/2018 – O2 EMC Partners with United Renewable Energy™ to Construct a 3.3 MW Solar Project to serve the town of Bedford, VA; 26/03/2018 – VP Lovell Disposes 559 Of EMC Insurance Group Inc; 06/03/2018 – VP Phillips Disposes 329 Of EMC Insurance Group Inc; 23/04/2018 – BAE Systems and Dell EMC collaborate to offer mission-ready cloud solution for the U.S. Government; 23/05/2018 – Graham Porter, Dell EMC, Business Development Director EMEA, Talks About Security Threats, Solutions and GDPR “In The Boardroom” On SecuritySolutionsWatch.com; 26/03/2018 – VP Jean Disposes 559 Of EMC Insurance Group Inc; 16/04/2018 – EMC INSURANCE GROUP INC EMCI.O FY2018 SHR VIEW $1.55 — THOMSON REUTERS l/B/E/S; 06/03/2018 – VP Nigut Disposes 358 Of EMC Insurance Group Inc

Investors sentiment increased to 1.62 in Q1 2018. Its up 0.42, from 1.2 in 2017Q4. It improved, as 10 investors sold Meridian Bioscience, Inc. shares while 45 reduced holdings. 28 funds opened positions while 61 raised stakes. 36.20 million shares or 0.87% less from 36.52 million shares in 2017Q4 were reported. Tudor Inv Et Al holds 39,304 shares or 0.02% of its portfolio. Louisiana State Employees Retirement accumulated 0.01% or 18,800 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Corp reported 31,600 shares. Verity Asset Mgmt Inc invested in 0.27% or 20,999 shares. State Of New Jersey Common Pension Fund D invested in 50,000 shares. Koch Indus has invested 0.02% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Highbridge Cap Mngmt Limited Liability Corp has 22,723 shares. Martingale Asset Mngmt Lp holds 0.05% or 268,000 shares in its portfolio. Commercial Bank Of New York Mellon Corporation has 0% invested in Meridian Bioscience, Inc. (NASDAQ:VIVO). 32,194 were reported by Manufacturers Life Insurance Co The. Advisors Preferred Ltd Limited Liability Company reported 4,603 shares stake. Blackrock invested in 0% or 5.38M shares. The Pennsylvania-based Vanguard Inc has invested 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Pinebridge Ltd Partnership, a New York-based fund reported 17,049 shares. Envestnet Asset Mngmt Inc invested 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO).

Among 5 analysts covering Meridian Bioscience (NASDAQ:VIVO), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Meridian Bioscience had 13 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, January 25 by Canaccord Genuity. Piper Jaffray maintained it with “Sell” rating and $10.0 target in Thursday, October 19 report. The stock has “Hold” rating by Robert W. Baird on Thursday, October 19. The stock of Meridian Bioscience, Inc. (NASDAQ:VIVO) has “Hold” rating given on Thursday, September 10 by Canaccord Genuity. The firm has “Sell” rating given on Thursday, September 21 by Piper Jaffray. The stock of Meridian Bioscience, Inc. (NASDAQ:VIVO) earned “Buy” rating by Hilliard Lyons on Monday, March 28. The stock of Meridian Bioscience, Inc. (NASDAQ:VIVO) earned “Sell” rating by Piper Jaffray on Thursday, January 25. Hilliard Lyons downgraded Meridian Bioscience, Inc. (NASDAQ:VIVO) on Monday, March 21 to “Neutral” rating. The firm has “Sell” rating by Piper Jaffray given on Thursday, July 27. Robert W. Baird maintained the stock with “Hold” rating in Thursday, January 25 report.

More news for Meridian Bioscience, Inc. (NASDAQ:VIVO) were recently published by: Nasdaq.com, which released: “Meridian Introduces Critical Raw Materials for Nipah Virus Diagnosis, a Key Emerging Disease on the WHO’s Priority List” on May 30, 2018. Nasdaq.com‘s article titled: “Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience …” and published on May 29, 2018 is yet another important article.

Since February 7, 2018, it had 2 insider buys, and 0 selling transactions for $28,784 activity. Rice John McCune Jr. bought $14,750 worth of Meridian Bioscience, Inc. (NASDAQ:VIVO) on Wednesday, February 7. $14,034 worth of Meridian Bioscience, Inc. (NASDAQ:VIVO) was bought by McIlwraith John on Friday, February 23.

Meridian Bioscience, Inc., a life science company, develops, makes, distributes, and sells diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide. The company has market cap of $671.16 million. The firm operates through Diagnostics and Life Science divisions. It has a 31.08 P/E ratio. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the illumigene brand; rapid immunoassays, a single-use immunoassays that can be used in point-of-care settings under the TRU, ImmunoCard, and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the Premier brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare brand.

Since March 31, 2018, it had 0 buys, and 2 insider sales for $73,294 activity. 1,342 shares were sold by Nigut Elizabeth A, worth $34,557. SIMONETTA LISA ANNE had sold 1,487 shares worth $38,737 on Tuesday, June 5.

Investors sentiment increased to 1.52 in Q1 2018. Its up 0.04, from 1.48 in 2017Q4. It is positive, as 5 investors sold EMC Insurance Group Inc. shares while 18 reduced holdings. 5 funds opened positions while 30 raised stakes. 6.03 million shares or 0.09% less from 6.03 million shares in 2017Q4 were reported. Pnc Fincl Svcs Group has 25 shares for 0% of their portfolio. Mairs & Power has 0.06% invested in EMC Insurance Group Inc. (NASDAQ:EMCI) for 190,528 shares. California State Teachers Retirement Sys holds 13,348 shares or 0% of its portfolio. Millennium Mngmt Limited Liability Com owns 0% invested in EMC Insurance Group Inc. (NASDAQ:EMCI) for 23,112 shares. Jnba Finance Advisors invested 0.02% in EMC Insurance Group Inc. (NASDAQ:EMCI). Ameriprise Financial Inc owns 180,949 shares or 0% of their US portfolio. Prelude Cap Mgmt holds 5,640 shares. Moreover, Natl Bank Of Ny Mellon has 0% invested in EMC Insurance Group Inc. (NASDAQ:EMCI). 10,546 were reported by Rhumbline Advisers. The New York-based Amer Intll has invested 0% in EMC Insurance Group Inc. (NASDAQ:EMCI). Blackrock reported 0% stake. Deutsche Financial Bank Ag reported 43,493 shares. Dalton Greiner Hartman Maher And Company reported 130,431 shares. First Ltd Partnership stated it has 8,450 shares. Brandywine Global Management Ltd Liability Corp reported 0% in EMC Insurance Group Inc. (NASDAQ:EMCI).

Among 2 analysts covering EMC Insurance Group (NASDAQ:EMCI), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. EMC Insurance Group had 9 analyst reports since September 9, 2015 according to SRatingsIntel. The stock of EMC Insurance Group Inc. (NASDAQ:EMCI) earned “Hold” rating by Sandler O’Neill on Friday, April 6. The firm has “Hold” rating given on Thursday, August 17 by Keefe Bruyette & Woods. The firm has “Buy” rating by Sandler O’Neill given on Wednesday, January 20. The firm has “Hold” rating given on Friday, December 18 by Sandler O’Neill. The company was upgraded on Wednesday, September 9 by Sandler O’Neill. The rating was initiated by Keefe Bruyette & Woods with “Market Perform” on Tuesday, October 20. The firm earned “Hold” rating on Wednesday, September 20 by Keefe Bruyette & Woods. The firm earned “Hold” rating on Monday, April 16 by Keefe Bruyette & Woods. The stock of EMC Insurance Group Inc. (NASDAQ:EMCI) has “Hold” rating given on Thursday, February 8 by Keefe Bruyette & Woods.

Meridian Bioscience, Inc. (NASDAQ:VIVO) Institutional Positions Chart